| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 6.885 | 24.089 | 12.358 | 19.196 | 22.919 | 39.592 |
| Total Income - EUR | - | - | - | - | 6.886 | 24.112 | 24.747 | 19.196 | 22.959 | 39.592 |
| Total Expenses - EUR | - | - | - | - | 165 | 2.374 | 10.732 | 2.427 | 898 | 3.694 |
| Gross Profit/Loss - EUR | - | - | - | - | 6.720 | 21.738 | 14.015 | 16.769 | 22.061 | 35.898 |
| Net Profit/Loss - EUR | - | - | - | - | 6.514 | 21.521 | 13.273 | 16.317 | 18.531 | 29.746 |
| Employees | - | - | - | - | 0 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Barbu Hema-Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | 6.803 | 24.494 | 35.472 | 17.940 | 33.763 | 34.038 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 1.267 | 2.619 | 3.204 | 5.191 | 6.727 | 18.591 |
| Cash | - | - | - | - | 5.536 | 21.874 | 32.268 | 12.749 | 27.037 | 15.447 |
| Shareholders Funds | - | - | - | - | 6.556 | 24.438 | 33.732 | 16.357 | 31.763 | 29.787 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 247 | 56 | 1.740 | 1.582 | 2.001 | 4.251 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Barbu Hema-Med S.r.l.